Literature DB >> 32236998

Solidarity and transparency against the COVID-19 pandemic.

Gulhima Arora1, George Kroumpouzos2,3, Martin Kassir4, Mohammad Jafferany5, Torello Lotti6, Roxanna Sadoughifar7,8, Zuzanna Sitkowska9, Stephan Grabbe10, Mohamad Goldust7,11,12.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32236998      PMCID: PMC7228210          DOI: 10.1111/dth.13359

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


× No keyword cloud information.
Dear Editor Since December 2019, coronavirus (CoV) disease 2019 (COVID‐19) has spread rapidly throughout the world, and World Health Organization (WHO) declared it a health emergency, and most recently, pandemic. More than 100 countries including developed and underdeveloped ones have been affected. Public health approach and strategies may be similar in such situations around the world; however, developing and poor countries lack an adequate health care system to wage a strong attack. The approach of developed countries such as China and Italy to detect and isolate cases, prevent transmission, and detect susceptible hosts has been encouraging. It includes quarantine, social distancing, and isolation. However, such strategy is difficult to follow in developing countries, due to lack of surveillance resources, appropriate technology, and funds. In addition, the poorer countries carry a higher risk of increased morbidity and mortality due to overcrowding and large population sizes and densities. Furthermore, lack of accurate diagnostic methods places them in a more vulnerable situation due to inadequate source identification. Individual behaviors such as self‐isolation, social distancing, and accessing health care only if symptoms are severe, may be lacking in poorer countries due to inadequate information and illiteracy. Dispersion of misinformation and false beliefs are also more common. Amidst this somber situation, the blame of “politics of epidemics” in which politics mostly attributes to the broad effect of local, national, and international establishments, on the health consequences of communities in disease outbreaks, in Asian countries like India and Iran is challenging. This has been attributed to various factors and sentiments, for example, fear of low tourist inflow causing recession or fear of creating panic in the public. This is in sharp contrast to developed countries like Italy, whose transparency helps developing appropriate strategies. As we have entered a pandemic, we need to act fast and right. Furthermore, solidarity must define our onward battle. WHO develops plans based on the principle of solidarity among countries such as gathering the world's leading experts for discussions on top research and innovation. It also works with member states to promote knowledge and empower communities. By working together, countries promote efficiency. Cooperation is a key weapon in the battle against COVID‐19. We each need to recognize our unique risks, the prevailing cultural and social practices in our region and work a way around. Let us stand together in solidarity, beyond borders as “The Human Race,” to fight and overcome the COVID‐19 threat.
  6 in total

1.  Solidarity and transparency against the COVID-19 pandemic.

Authors:  Gulhima Arora; George Kroumpouzos; Martin Kassir; Mohammad Jafferany; Torello Lotti; Roxanna Sadoughifar; Zuzanna Sitkowska; Stephan Grabbe; Mohamad Goldust
Journal:  Dermatol Ther       Date:  2020-04-13       Impact factor: 2.851

2.  COVID-19: what is next for public health?

Authors:  David L Heymann; Nahoko Shindo
Journal:  Lancet       Date:  2020-02-13       Impact factor: 79.321

3.  The Politics of Disease Epidemics: a Comparative Analysis of the SARS, Zika, and Ebola Outbreaks.

Authors:  Lydia Kapiriri; Alison Ross
Journal:  Glob Soc Welf       Date:  2018-09-03

4.  Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts.

Authors:  Joel Hellewell; Sam Abbott; Amy Gimma; Nikos I Bosse; Christopher I Jarvis; Timothy W Russell; James D Munday; Adam J Kucharski; W John Edmunds; Sebastian Funk; Rosalind M Eggo
Journal:  Lancet Glob Health       Date:  2020-02-28       Impact factor: 26.763

Review 5.  World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19).

Authors:  Catrin Sohrabi; Zaid Alsafi; Niamh O'Neill; Mehdi Khan; Ahmed Kerwan; Ahmed Al-Jabir; Christos Iosifidis; Riaz Agha
Journal:  Int J Surg       Date:  2020-02-26       Impact factor: 6.071

6.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

  6 in total
  16 in total

1.  Research on International Cooperative Governance of the COVID-19.

Authors:  Xueyu Lin; Hualei Yang; Yuanyang Wu; Xiaodong Zheng; Lin Xie; Zheng Shen; Sen Hu
Journal:  Front Public Health       Date:  2021-04-29

2.  Dermatologic treatments in the era of COVID-19 pandemic-Data and Hypothesis.

Authors:  Roxanna Sadoughifar; Mohamad Goldust; George Kroumpouzos; Jacek C Szepietowski; Torello Lotti; Sunmeet Sandhu
Journal:  Dermatol Ther       Date:  2020-05-26       Impact factor: 2.851

3.  Mental health status of dermatologists during the COVID-19 pandemic: A technology-based therapy.

Authors:  Mohamad Goldust; Komal Agarwal; George Kroumpouzos; Mohammad Jafferany; Torello Lotti; Indrashis Podder
Journal:  Dermatol Ther       Date:  2020-06-19       Impact factor: 3.858

4.  Shifting dermatology market strategies from cosmetics to moisturizers and sanitizers treatments in COVID-19 era.

Authors:  Robert A Schwartz; Swetalina Pradhan; Hassan Galadari; Torello Lotti; Aseem Sharma; Mohamad Goldust
Journal:  Dermatol Ther       Date:  2020-07-07       Impact factor: 3.858

5.  COVID 19 and its impact on cosmetic dermatology.

Authors:  Hassan Galadari; Atula Gupta; George Kroumpouzos; Martin Kassir; Lidia Rudnicka; Torello Lotti; Roberta Vasconcelos Berg; Mohamad Goldust
Journal:  Dermatol Ther       Date:  2020-07-01       Impact factor: 3.858

6.  Solidarity and transparency against the COVID-19 pandemic.

Authors:  Gulhima Arora; George Kroumpouzos; Martin Kassir; Mohammad Jafferany; Torello Lotti; Roxanna Sadoughifar; Zuzanna Sitkowska; Stephan Grabbe; Mohamad Goldust
Journal:  Dermatol Ther       Date:  2020-04-13       Impact factor: 2.851

7.  A dermatologist's perspective of the COVID-19 outbreak.

Authors:  Dedee F Murrell; Gulhima Arora; Lidia Rudnicka; Martin Kassir; Torello Lotti; Mohamad Goldust
Journal:  Dermatol Ther       Date:  2020-06-23       Impact factor: 3.858

8.  Use of face masks in dermatology department during the COVID-19 outbreak.

Authors:  Mohamad Goldust; George Kroumpouzos; Dedee F Murrell; Mohammad Jafferany; Torello Lotti; Uwe Wollina; Swathi Shivakumar
Journal:  Dermatol Ther       Date:  2020-06-12       Impact factor: 3.858

9.  Where do we stand as dermatologists in combat with COVID-19.

Authors:  Mohamad Goldust; Swathi Shivakumar; George Kroumpouzos; Dedee F Murrell; Simon M Mueller; Alexander A Navarini
Journal:  Dermatol Ther       Date:  2020-06-23       Impact factor: 3.858

Review 10.  Utility and risk of dermatologic medications during the COVID-19 pandemic.

Authors:  Mohamad Goldust; Karin Hartmann; Ayman Abdelmaksoud; Alexander A Navarini
Journal:  Dermatol Ther       Date:  2020-08-05       Impact factor: 3.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.